about
Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosineCytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivoEffects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652.Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinoma.In vivo administration of recombinant interleukin-2 induces granulocyte-macrophage colony formation in a murine system.Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.Systemic administration of recombinant methionyl human interleukin-2 (Ala 125) to cancer patients: clinical results.Treatment of renal cell carcinoma with daily low-dose alpha-interferon.Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2.Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.Treatment of immunodeficiency with interleukin-2: initial exploration.Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancer.Interleukin-6 induction by a muramyltripeptide derivative in cancer patients.Comparative effects of soluble and particulate glucans on survival in irradiated mice.Soluble polyglycans enhance recovery from cobalt-60--induced hemopoietic injury.Isolation of a nonendotoxic antitumor preparation from Serratia marcescens.Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (accutane).Effects of poly(I,C)-LC on growth and differentiation of normal and malignant myelopoietic progenitor cells.Immunomodulation of T cell deficiency in humans by thymic humoral factor: from crude extract to synthetic thymic humoral factor-gamma 2.Integrated etiopathogenesis of cancer of mucosal surfaces with emphasis on the digestive tract: an appraisal.The optimal technological approach to the development of human hybridomas.Therapeutic applications of antiidiotypic antibodies.Gamma-interferon: physiology and speculation on its role in medicine.Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?Problems associated with radioimmunodetection and possibilities for future solutions.The biological modification of tumor cells as a means of inducing their regression: an overview.Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.Prospects for the therapeutic use of human monoclonal antibodies.A randomized trial of low doses of alpha interferon in patients with breast cancer.Antibody-toxin hybrids: a clinical review of their use.Immunotherapy: the old and the new.Potential for specific cancer therapy with immune T lymphocytes.Cell-mediated reactivity to human tumor-type associated antigens: does it exist?
P1433
Q28330322-54C7D229-6A44-406D-95C4-389AF25077FBQ28338909-ED581CAF-86E8-4FD0-BACB-494E6C0859D7Q33373062-FCAEFDB0-CC4B-4CE7-B969-F81AD77E0AC7Q33404610-85B6D53B-FFA9-49AD-93A9-B3F415BE1B6DQ33404612-AA6C5D6B-8657-4D6F-B93E-827C4710F735Q33409815-1930168C-3045-4291-81BA-4C5A2EEB01D2Q33409817-A53AF5C6-61FF-45EB-A7AF-4F466CF1ACB0Q33411185-689956AD-68CE-4B30-8D69-3B32DD7A9613Q33436729-21271889-78A3-42C3-A02A-553368590870Q33437552-95DB76E4-9AE8-4F39-9DC1-61AAE3036E8FQ33437556-6B2982FA-860B-4AC2-9684-C11EF243EC16Q33437559-92EE593F-39B7-40B4-A051-32BA9B483117Q33452687-42E69FEE-05A6-4A82-A480-CDB6B79F3793Q33477030-3E0BFB51-FA19-407C-B3E8-F0252F148B24Q33479870-DE73B62F-0597-4EAA-8F23-F140989407F5Q33480139-B6898718-7FC4-458D-9C3E-37ABF2C94BE2Q34256012-6FCAF68C-696C-47F6-AE39-F4F8D8777A4AQ34454485-B74ED41E-28E3-4360-94D3-386A26C3942BQ34637891-C9E69783-C3D7-4550-8A05-448AF398B451Q34648442-9B769901-03C3-46A1-86A5-FF17C82CBE40Q34694772-C0A0DDA5-8C76-4E40-AF6C-7AE8757BC29AQ34710970-6538D95F-8342-4354-82F8-5D65DF52650CQ36445908-F44DF9CA-2ACE-4D1E-BD52-EE491C8FCAEDQ36458358-4D6764FE-A4C6-4278-95AB-A00AA732D60EQ36487927-63D98918-6066-417C-BA33-549422FC2C90Q37945376-B2CDD4CE-FFE7-4B46-86C5-3D1FF3093499Q38606478-1DDB1AA0-4115-4EB9-94EB-6066EDD7B771Q39495474-9AABFBA1-B0F7-4EA1-B08C-C5D5CAD52C81Q39527794-11AA3A5E-AD48-498B-95B5-0B94B9860DBCQ39595639-7136E69F-CE79-401F-BA46-2A053D113058Q39659592-2C08F906-9DD4-40E2-A6FB-15B88D073730Q39659598-DD57A4C6-89CB-460A-A3EB-0B3E77660A04Q39730361-2AE0944C-49E0-411F-82F4-3EF73F246D4CQ39730368-F7D5023F-4734-4642-85FF-C9C7B9F8BE96Q39746243-7B7A0B97-6011-4260-A02C-BE832A5485BEQ39791151-4566D4C1-0263-47C9-A82A-B6351D58DE4FQ39850360-3A8F560D-3435-4B28-A517-78C6ABECD866Q40108520-881C7B8B-175F-4CCE-AAE6-8CA7D6FCBA9BQ40117214-3C1ED239-A1B0-48AD-B88E-61CF9E53D1DFQ40163881-7DB53352-CF90-49A9-B78B-6394BEB3DE51
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of biological response modifiers
@ast
Journal of biological response modifiers
@en
Journal of biological response modifiers
@es
Journal of biological response modifiers
@it
Journal of biological response modifiers
@nl
type
label
Journal of biological response modifiers
@ast
Journal of biological response modifiers
@en
Journal of biological response modifiers
@es
Journal of biological response modifiers
@it
Journal of biological response modifiers
@nl
altLabel
J Biol Response Mod
@en
prefLabel
Journal of biological response modifiers
@ast
Journal of biological response modifiers
@en
Journal of biological response modifiers
@es
Journal of biological response modifiers
@it
Journal of biological response modifiers
@nl
P1055
P1156
P1476
Journal of biological response modifiers
@en